Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
UBS
Federal Trade Commission
Queensland Health
Medtronic
Farmers Insurance
Express Scripts
Argus Health

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020220

« Back to Dashboard

NDA 020220 describes ULTRAVIST 370, which is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the ULTRAVIST 370 profile page.

The generic ingredient in ULTRAVIST 370 is iopromide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopromide profile page.
Summary for 020220
Tradename:ULTRAVIST 370
Applicant:Bayer Hlthcare
Ingredient:iopromide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020220
Mechanism of ActionX-Ray Contrast Activity
Suppliers and Packaging for NDA: 020220
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ULTRAVIST 150 iopromide INJECTABLE;INJECTION 020220 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-342 N 50419-342-21
ULTRAVIST 150 iopromide INJECTABLE;INJECTION 020220 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-342 N 50419-342-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength76.9%
Approval Date:May 10, 1995TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength62.3%
Approval Date:May 10, 1995TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength49.9%
Approval Date:May 10, 1995TE:RLD:Yes

Expired US Patents for NDA 020220

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare ULTRAVIST 240 iopromide INJECTABLE;INJECTION 020220-003 May 10, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare ULTRAVIST 150 iopromide INJECTABLE;INJECTION 020220-004 May 10, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare ULTRAVIST 370 iopromide INJECTABLE;INJECTION 020220-001 May 10, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare ULTRAVIST 300 iopromide INJECTABLE;INJECTION 020220-002 May 10, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Cantor Fitzgerald
Medtronic
Boehringer Ingelheim
McKesson
Dow
Farmers Insurance
Julphar
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.